APRIL 09
Formal establishment of company and opening of research centers in Prague and Brno.

MARCH 09
PCT application on novel adjuvants and immunomodulators.

JANUARY 09
IOCB, VRI, ImuThes, and LSC agree to establish Mendel Therapeutics by contributing patented compounds, know-how and start-up management skills to the new venture.